BELLEVUE, WA, March 12 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY),
a biotechnology company specializing in the development of innovative
therapeutic products for the treatment of cancer, today announced that Robert
Kirkman, M.D., President and Chief Executive Officer, is scheduled to present
at two upcoming investment conferences.
The first presentation is scheduled to take place at the Invest Northwest
CEO and Investor Forum at 4:10 p.m. Pacific Time on March 18 in Seattle. The
second presentation is scheduled to take place at the Cowen & Co. 28th Annual
Health Care Conference at 10:15 a.m. Eastern Time on March 20 in Boston.
A live and archived webcast of Dr. Kirkman's presentation at the Cowen &
Co. Conference will be webcast and can be accessed at www.oncothyreon.com
under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
For further information:
For further information: Investor and Media Relations Contact: Julie
Rathbun, Rathbun Communications, (206) 769-9219, firstname.lastname@example.org